COLLA, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 468
AS - Asia 206
EU - Europa 53
SA - Sud America 11
AF - Africa 7
OC - Oceania 1
Totale 746
Nazione #
US - Stati Uniti d'America 463
SG - Singapore 77
CN - Cina 71
TR - Turchia 30
DE - Germania 24
HK - Hong Kong 11
BR - Brasile 10
IT - Italia 7
SE - Svezia 6
IN - India 5
MX - Messico 4
PL - Polonia 4
ZA - Sudafrica 4
ES - Italia 3
JP - Giappone 2
KE - Kenya 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
FI - Finlandia 1
FR - Francia 1
GB - Regno Unito 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
RO - Romania 1
TH - Thailandia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 746
Città #
Dallas 306
Santa Clara 37
Frankfurt am Main 23
Singapore 19
Ashburn 13
Hong Kong 11
Beijing 9
Shanghai 9
Los Angeles 6
Stockholm 6
West Jordan 6
Guangzhou 5
Laurel 5
Assago 4
Johannesburg 4
New York 4
Warsaw 4
Baltimore 3
Jinhua 3
Phoenix 3
Seattle 3
Shenzhen 3
São Paulo 3
The Dalles 3
Boca Raton 2
Boston 2
Brooklyn 2
Buffalo 2
Chicago 2
Istanbul 2
Jiaxing 2
Jiujiang 2
Mexico City 2
Mumbai 2
Parma 2
San Francisco 2
San Jose 2
Tokyo 2
Almirante Tamandaré 1
Amsterdam 1
Baghdad 1
Bangkok 1
Belo Horizonte 1
Berrechid 1
Brasília 1
Carney 1
Caruaru 1
Cedar Knolls 1
Central City 1
Chennai 1
Clifton 1
Craiova 1
Foshan 1
Helsinki 1
Hurst 1
Hyderabad 1
Jakarta 1
Kent 1
Kintnersville 1
Lagoa do Tocantins 1
Long An 1
Melbourne 1
Mexicali 1
Mississauga 1
Montebello 1
Moore 1
Nairobi 1
Oakland 1
Oklahoma City 1
Paris 1
Parobé 1
Pasadena 1
Pinellas Park 1
Pune 1
Punta Gorda 1
Quanzhou 1
Raleigh 1
Reston 1
Riga 1
Rotherham 1
Rui'an 1
Salt Lake City 1
San Nicolás de los Garza 1
Sanming 1
Secaucus 1
Seoul 1
Sumaré 1
Taizhou 1
Tashkent 1
Thika 1
Ulan Bator 1
Varaždin 1
Waltham 1
Wuxi 1
Xuzhou 1
Zapala 1
Totale 578
Nome #
The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice 266
Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y(+) 23
Nuclear localization signal of TonEBP is regulated by changes in tonicity 22
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 21
TonEBP is inhibited by RNA helicase A via interaction involving the E ' F loop 20
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 19
Subcellular localization of alpha-synuclein aggregates and their interaction with membranes 19
Toxic alpha-synuclein oligomer accumulation and endoplasmic reticulum stress is mechanistically linked to alpha-synucleinopathy in vivo 19
Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease. 19
Microbiome, Parkinson's Disease and Molecular Mimicry 18
DNA-dependent protein kinase (DNA-PK) and Ataxia-Telengiectasia Mutated (ATM) protect cells from hypertonic stress by activating TonEBP transcriptional activator 18
Endoplasmic Reticulum Stress Is Important for the Manifestations of alpha-Synucleinopathy In Vivo 18
Accumulation of Toxic alpha-Synuclein Oligomer within Endoplasmic Reticulum Occurs in alpha-Synucleinopathy In Vivo 18
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy 18
Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy 17
Linking the endoplasmic reticulum to Parkinson’s disease and alpha-synucleinopathy 17
Exogenous administration of microsomes-associated alpha-synuclein aggregates to primary neurons as a powerful cell model of fibrils formation 17
Novel nuclear localization signal regulated by ambient tonicity in vertebrates 17
Endoplasmic reticulum stress is associated with alpha-synucleinopathy in transgenic mice model 17
SYNUCLEIN DEPENDENT NEURODEGENERATION AND NEUROPROTECTION IN VIVO: IMPLICATIONS FOR PATHOGENESIS OF PARKINSON'S DISEASE 16
LPS and TNF alpha increase arginine transport and CAT-2 expression in cultured human endothelial cells 16
Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD 16
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 16
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations 15
Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: what is new? 15
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 15
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 14
Multiple domains of TonEBP cooperate to stimulate transcription in response to hypertonicity 14
DNA-dependent protein kinase (DNA-PK) phosphorylates and activates TonEBP/NFAT5 in response to hypertonicity 14
LPS and TNF alpha increase arginine transport but not nitric oxide production in cultured human endothelial cells 14
RNA helicase a modulates activity of TonEBP/NFAT5 transcriptional activator in hypertonicity 12
Totale 780
Categoria #
all - tutte 7.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202494 0 0 0 0 0 2 0 46 2 7 4 33
2024/2025245 22 40 24 2 4 32 33 12 20 2 13 41
2025/2026441 63 119 235 24 0 0 0 0 0 0 0 0
Totale 780